期刊文献+

2型糖尿病患者眼底改变与临床表型关联研究进展 被引量:2

下载PDF
导出
摘要 糖尿病性视网膜病变(DR)是糖尿病最常见的并发症之一,常造成患者视力减退或失明。尽管基于眼底图像的DR计算机辅助筛查技术取得重大进展,但目前DR筛查系统大多数只提取图像信息,并未与患者临床表型信息关联。2型糖尿病患者的临床表型存在明显异质性,影响眼底病变的因素众多。本文主要围绕2型糖尿病患者眼底改变与临床表型如症状、体征及血液生化指标之间的关系进行综述,为今后结合临床电子病历中的数据特征,研发精准筛查DR模型奠定基础。
出处 《交通医学》 2019年第5期453-456,共4页 Medical Journal of Communications
基金 国家重点研发计划(2018YFC1314900,2018YFC1314902) 国家级大学生创业训练与实践项目(201810304138K) 江苏省大学生创新创业训练计划项目(201910304108Y) 江苏省高校“青蓝工程” 南通市第五期“226工程”
  • 相关文献

参考文献1

二级参考文献15

  • 1Aveleira CA, Lin CM, Abcouwer SF, et al. TNF-cL signals through PKC/NF-KB to alter the tight junction complex and increase retinal endothelial cell ermeability. Diabetes ,2010 ,59 ( 11 ) :2872-2782.
  • 2Neuparth MJ, Proena JB, Santos-Silva A, et al. The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. J Cell Mol Med ,2014 , 18 (7) : 1313-13,20.
  • 3Fiil6p P, Seres I, Lrincz H, et al. Association of chemefin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients. J Cell Mol Meal,18(7) :1313-13,20.
  • 4Herenius MM, Oliveira AS, Wijbrandts CA, et al. Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS One ,2013,8(2) : e57802.
  • 5Studholme S. Diabetic retinopathy. J Perioper Pract ,2008 , ( 5 ) : ,205-210.
  • 6Segersvard R, Tsai JA, Herrington MK, et al. Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis. Obesity ( Silver Spring) ,2008 , 16( 1 ) :23-28.
  • 7Bozaoglu K, Bohon K, McMillan J, et al . Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology ,2007 , 148 ( 10 ) :4687-4694.
  • 8Wang D, Yuan GY, Wang XZ, et al. Plasma chemerin level in metabolic syndrome. Genet Mol Res ,2013 ,12(4) :5986-5991.
  • 9Emst MC, Issa M, Goralski KB,et al. Chemefin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology ,2010, 151 (5) : ,1998-,2007.
  • 10Bozaoglu K, Segal D, Shields KA ,et al. Chemefin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab ,2009 ,94 ( 8 ) :3085-3088.

共引文献6

同被引文献30

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部